Sedana Medical AB Market Cap ($99.42 Million)
Market Cap & Net Worth: Sedana Medical AB (SEDANA)
Sedana Medical AB market cap. Sedana Medical AB (ST:SEDANA) has a market capitalization of $99.42 Million (Skr923.83 Million) as of November 5, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #19024 globally and #331 in its home market, demonstrating a -5.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sedana Medical AB's stock price Skr9.30 by its total outstanding shares 99336960 (99.34 Million). Also see Sedana Medical AB cash flow conversion for how efficiently the company converts equity into cash flow.
Sedana Medical AB Market Cap History (2017–2026)
Sedana Medical AB market cap history from 2017 to 2026. Data shows growth from $101.56 Million to $99.42 Million (4.88% CAGR). Check SEDANA stock price and chart for real-time trading data and today's change.
Sedana Medical AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sedana Medical AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SEDANA shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.55x
Sedana Medical AB's market cap is 0.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $101.56 Million | $40.43 Million | -$3.88 Million | 2.51x | N/A |
| 2018 | $207.93 Million | $57.90 Million | -$6.87 Million | 3.59x | N/A |
| 2019 | $362.93 Million | $71.65 Million | -$16.36 Million | 5.07x | N/A |
| 2020 | $916.69 Million | $141.77 Million | -$27.14 Million | 6.47x | N/A |
| 2021 | $1.05 Billion | $159.15 Million | -$57.97 Million | 6.59x | N/A |
| 2022 | $199.91 Million | $122.86 Million | -$73.51 Million | 1.63x | N/A |
| 2023 | $247.59 Million | $153.87 Million | -$59.61 Million | 1.61x | N/A |
| 2024 | $203.97 Million | $178.75 Million | -$10.67 Million | 1.14x | N/A |
| 2025 | $109.90 Million | $200.23 Million | -$59.24 Million | 0.55x | N/A |
Competitor Companies of SEDANA by Market Capitalization
Companies near Sedana Medical AB in the global market cap rankings as of November 5, 2026. Also see SEDANA total assets for a full breakdown of the balance sheet.
Key companies related to Sedana Medical AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Sedana Medical AB (2017–2026)
Market capitalization of Sedana Medical AB from 2017 to today. Between 2017 and today, Sedana Medical AB's market cap moved from $101.56 Million to $ 99.42 Million, with a yearly change of 4.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr99.42 Million | -9.53% |
| 2025 | Skr109.90 Million | -46.12% |
| 2024 | Skr203.97 Million | -17.62% |
| 2023 | Skr247.59 Million | +23.85% |
| 2022 | Skr199.91 Million | -80.93% |
| 2021 | Skr1.05 Billion | +14.34% |
| 2020 | Skr916.69 Million | +152.58% |
| 2019 | Skr362.93 Million | +74.55% |
| 2018 | Skr207.93 Million | +104.74% |
| 2017 | Skr101.56 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Sedana Medical AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $99.42 Million USD |
| MoneyControl | $99.42 Million USD |
| MarketWatch | $99.42 Million USD |
| marketcap.company | $99.42 Million USD |
| Reuters | $99.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the c… Read more